Nuclear fusion energy company Helion has completed a new round of financing at a valuation of approximately $15.5 billion, led by investment firm Thrive.

Source: PANews2026/06/04 22:27

If you have any feedback or questions about this content, please contact us at crypto.news@kcex.com

PANews reported on June 4th that Helion, a nuclear fusion energy startup backed by OpenAI co-founder Sam Altman, has completed a new round of financing, bringing its latest valuation to approximately $15.5 billion, nearly tripling its previous valuation. This round was led by investment firm Thrive, with participation from other technology and financial investors. Helion is advancing its commercial nuclear fusion power generation project and plans to use the new funds to expand its power generation and experimental facilities, accelerate the verification of key technologies, and pursue long-term power supply agreements with electricity purchasers to support the deployment of its first commercial nuclear fusion power plants.

Nuclear fusion energy company Helion has completed a new round of financing at a valuation of approximately $15.5 billion, led by investment firm Thrive.

Share to:

Author: PA一线

This content is for market information only and is not investment advice.

Follow PANews official accounts, navigate bull and bear markets together

Recommended Reading

Related Topics

PANews App

24/7 blockchain news tracking and in-depth analysis.

Disclaimer: The articles reposted on this website are sourced from public platforms and are for reference only. These articles do not represent the views or opinions of KCEX. All copyrights belong to the original authors. If you believe that any reposted article infringes upon the rights of a third party, please contact crypto.news@kcex.com for removal. KCEX makes no representations or warranties regarding the timeliness, accuracy, or completeness of reposted articles, and shall not be liable for any actions or decisions made based on such content. Reposted materials are for informational purposes only and do not constitute advice, endorsement, or basis for any commercial, financial, legal, and/or tax decisions.